ISRCTN57549638进行中（未招募）未知
Prevention of bleeding in haemophilia A by prophylactic treatment with Octanate®, Wilate®, Nuwiq®: a prospective, multi-national, non-interventional study to evaluate routine practice prophylactic treatment schedules – NIS-Previq
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 19/03/2024:
- •1. Haemophilia A
- •2. Treated with Octanate®, Wilate®or Nuwiq®
- •3. Prophylactic treatment schedule for at least 6 months is to be expected
- •4. Good compliance regarding documentation of FVIII treatments and bleeding episodes (in case home treatment is performed)
- •Previous inclusion criteria:
- •1. Haemophilia A
- •2. Treated with Nuwiq
- •3. Prophylactic treatment schedule for at least 6 months is to be expected
- •4. Good compliance regarding documentation of FVIII treatments and bleeding episodes (in case home treatment is performed)
排除标准
- •Patients with known contraindications as specified in the SPC
研究者
相似试验
招募中
不适用
Joint distraction in the treatment of haemophilic ankle arthropathy: clinical and structural efficacy, a pilot studybleeding disorderhaemophilia1008362410023213NL-OMON46992Academisch Medisch Centrum10
招募中
不适用
Platelet inhibition to reduce formation of non-alcohol steatohepatitis in cardiovascular patientsnon-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH)DRKS00013025niversitätsklinikum Tübingen150
已完成
3 期
A Randomised Controlled Trial to Compare Administration of Prothrombin Complex Concentrate with Standard Haemostasis Management in Adult Patients Undergoing Peritoneal Cytoreductive Surgery Requiring Massive Transfusion.Patients undergoing peritoneal cytoreductive surgeryPeritoneal cancerSurgery - Other surgeryCancer - Ovarian and primary peritonealACTRN12612001002875St George Hospital80
进行中（未招募）
不适用
Study of Safety and Efficacy of Antihemophilic Factor / von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjectswith von Willebrand’s DiseaseEUCTR2004-004868-69-ATZLB Behring LLC30
进行中（未招募）
不适用
Study of Safety and Efficacy of Antihemophilic Factor / von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjectswith von Willebrand’s DiseaseEUCTR2004-004868-69-SEZLB Behring LLC30